{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:11Z","timestamp":1791228671114,"version":"4.1.0"},"reference-count":279,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M710776"],"award-info":[{"award-number":["2022M710776"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2019-I2M-5-060"],"award-info":[{"award-number":["2019-I2M-5-060"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20220094"],"award-info":[{"award-number":["BX20220094"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016983","name":"Shanghai Clinical Research Center","doi-asserted-by":"publisher","award":["19MC1910300"],"award-info":[{"award-number":["19MC1910300"]}],"id":[{"id":"10.13039\/501100016983","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870182"],"award-info":[{"award-number":["81870182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170334"],"award-info":[{"award-number":["82170334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200290"],"award-info":[{"award-number":["82200290"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2288101"],"award-info":[{"award-number":["T2288101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.scib.2023.07.032","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T23:13:42Z","timestamp":1690326822000},"page":"1954-1974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies"],"prefix":"10.1016","volume":"68","author":[{"given":"Yiqing","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2023.07.032_b0005","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1093\/eurheartj\/ehac448","article-title":"Panvascular medicine: an emerging discipline focusing on atherosclerotic diseases","volume":"43","author":"Zhou","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.scib.2023.07.032_b0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: ic from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.scib.2023.07.032_b0015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCRESAHA.121.319815","article-title":"Endothelial senescence: a new age in pulmonary hypertension","volume":"130","author":"Culley","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0020","doi-asserted-by":"crossref","first-page":"899","DOI":"10.33963\/KP.15034","article-title":"The cardio-vascular future of panvascular medicine: the basics","volume":"77","author":"Musialek","year":"2019","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.scib.2023.07.032_b0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.molmed.2022.09.004","article-title":"Molecular basis and clinical implications of HIFs in cardiovascular diseases","volume":"28","author":"Hu","year":"2022","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.scib.2023.07.032_b0030","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","article-title":"Cellular adaptation to hypoxia through hypoxia inducible factors and beyond","volume":"21","author":"Lee","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0035","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.01-0944rev","article-title":"Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression","volume":"16","author":"Wenger","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0045","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.02-0445fje","article-title":"Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs","volume":"17","author":"Wiesener","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.scib.2023.07.032_b0060","doi-asserted-by":"crossref","first-page":"eabm3471","DOI":"10.1126\/sciadv.abm3471","article-title":"Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching","volume":"8","author":"Swiatlowska","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.scib.2023.07.032_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108186","article-title":"The role of hypoxia-inducible factors in cardiovascular diseases","volume":"238","author":"Yu","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.scib.2023.07.032_b0070","doi-asserted-by":"crossref","first-page":"e137557","DOI":"10.1172\/JCI137557","article-title":"HIF in the heart: development, metabolism, ischemia, and atherosclerosis","volume":"131","author":"Knutson","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0075","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1172\/JCI137558","article-title":"Hypoxia-inducible factor signaling in pulmonary hypertension","volume":"130","author":"Pullamsetti","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0080","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ckj\/sfac224","article-title":"Role of prolyl hydroxylase\/HIF-1 signaling in vascular calcification","volume":"16","author":"Negri","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.scib.2023.07.032_b0085","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.jvs.2017.09.030","article-title":"Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease","volume":"68","author":"Wang","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbcan.2018.07.002","article-title":"Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors","volume":"1870","author":"Samanta","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.scib.2023.07.032_b0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3945\/an.116.013912","article-title":"Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases","volume":"8","author":"Gugliucci","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.scib.2023.07.032_b0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.ph.47.030185.003213","article-title":"High-energy phosphate metabolism in vascular smooth muscle","volume":"47","author":"Butler","year":"1985","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2017.08.041","article-title":"Lactate dehydrogenase-A is indispensable for vascular smooth muscle cell proliferation and migration","volume":"492","author":"Kim","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.scib.2023.07.032_b0110","doi-asserted-by":"crossref","first-page":"L387","DOI":"10.1152\/ajplung.00285.2018","article-title":"Twisted HIF: revisiting smooth muscle HIF-1alpha signaling in pulmonary hypertension","volume":"315","author":"Shen","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2012.11.049","article-title":"CD146, a multi-functional molecule beyond adhesion","volume":"330","author":"Wang","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.scib.2023.07.032_b0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41392-020-00259-8","article-title":"CD146, from a melanoma cell adhesion molecule to a signaling receptor","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.scib.2023.07.032_b0125","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41467-019-11500-6","article-title":"CD146-HIF-1alpha hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension","volume":"10","author":"Luo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.07.032_b0130","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.24886","article-title":"Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis","volume":"126","author":"Pasquet","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.scib.2023.07.032_b0135","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1369\/0022155411428078","article-title":"Host-derived pericytes and Sca-1+ cells predominate in the MART-1- stroma fraction of experimentally induced melanoma","volume":"59","author":"Trevino-Villarreal","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.scib.2023.07.032_b0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10456-019-09682-0","article-title":"Glucose withdrawal induces endothelin 1 release with significant angiogenic effect from first trimester (FTM), but not term human umbilical cord perivascular cells (HUCPVC)","volume":"23","author":"Szaraz","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.scib.2023.07.032_b0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/2211-5463.13021","article-title":"Cardiac pericytes function as key vasoactive cells to regulate homeostasis and disease","volume":"11","author":"Lee","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.scib.2023.07.032_b0150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"Libby","year":"2019","journal-title":"Atherosclerosis Nat Rev Dis Primers"},{"key":"10.1016\/j.scib.2023.07.032_b0155","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/s41467-018-04447-7","article-title":"Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells","volume":"9","author":"Misra","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.07.032_b0160","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/ATVBAHA.115.306861","article-title":"Smooth muscle hypoxia-inducible factor 1\u03b1 links intravascular pressure and atherosclerosis\u2014brief report","volume":"36","author":"Liu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jcb.21757","article-title":"Regulation of HMG-CoA reductase expression by hypoxia","volume":"104","author":"Pallottini","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.scib.2023.07.032_b0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcm.2012.09.004","article-title":"Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages","volume":"23","author":"Parathath","year":"2013","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.scib.2023.07.032_b0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/CIRCRESAHA.111.246363","article-title":"Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism","volume":"109","author":"Parathath","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0180","doi-asserted-by":"crossref","first-page":"13531","DOI":"10.1073\/pnas.1735526100","article-title":"Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading","volume":"100","author":"Rong","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biocel.2009.10.002","article-title":"HIF-1beta determines ABCA1 expression under hypoxia in human macrophages","volume":"42","author":"Ugocsai","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0190","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/ATVBAHA.119.312434","article-title":"Smooth muscle cells contribute the majority of foam cells in ApoE (apolipoprotein E)-deficient mouse atherosclerosis","volume":"39","author":"Wang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0195","first-page":"136","article-title":"Smooth muscle cells in atherosclerosis: clones but not carbon copies. JVS: Vascular","volume":"2","author":"Espinosa-Diez","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.scib.2023.07.032_b0200","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0205","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1096\/fj.10-159806","article-title":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1","volume":"24","author":"Gimm","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0210","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1073\/pnas.70.6.1753","article-title":"Evidence for a monoclonal origin of human atherosclerotic plaques","volume":"70","author":"Benditt","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b0215","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1164\/rccm.200911-1663OC","article-title":"Hypoxia enhances platelet-derived growth factor signaling in the pulmonary vasculature by down-regulation of protein tyrosine phosphatases","volume":"183","author":"ten Freyhaus","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2023.07.032_b0220","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0225","doi-asserted-by":"crossref","first-page":"H2528","DOI":"10.1152\/ajpheart.01077.2005","article-title":"Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells","volume":"290","author":"Schultz","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20121344","article-title":"PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress","volume":"451","author":"Salabei","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.scib.2023.07.032_b0235","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.celrep.2018.03.043","article-title":"Cell autonomous and non-cell autonomous regulation of SMC progenitors in pulmonary hypertension","volume":"23","author":"Sheikh","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.scib.2023.07.032_b0240","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-10-4142","article-title":"The hypoxia-associated factor switches cells from HIF-1alpha- to HIF-2alpha-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion","volume":"71","author":"Koh","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b0245","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2023.07.032_b0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcp.28953","article-title":"HIF1alpha-induced upregulation of KLF4 promotes migration of human vascular smooth muscle cells under hypoxia","volume":"235","author":"Shan","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0255","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/ten.teb.2009.0630","article-title":"Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering","volume":"16","author":"Beamish","year":"2010","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1016\/j.scib.2023.07.032_b0260","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","article-title":"Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease","volume":"97","author":"Lacolley","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.scib.2023.07.032_b0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature02382","article-title":"Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression","volume":"428","author":"Wang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.07.032_b0270","first-page":"1023","article-title":"HTLV-1 tax induces expression of various immediate early serum responsive genes","volume":"6","author":"Fujii","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.scib.2023.07.032_b0275","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/cdd.2008.17","article-title":"Biology of hypoxia-inducible factor-2alpha in development and disease","volume":"15","author":"Patel","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.scib.2023.07.032_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110338","article-title":"Oxygen homeostasis and cardiovascular disease: a role for HIF?","volume":"128","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.scib.2023.07.032_b0285","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1158\/0008-5472.CAN-05-3345","article-title":"Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection","volume":"66","author":"Aprelikova","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b0290","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1083\/jcb.201303052","article-title":"Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy","volume":"203","author":"Rangrez","year":"2013","journal-title":"J Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/rr27","article-title":"Oxygen-regulated transcription factors and their role in pulmonary disease","volume":"1","author":"Semenza","year":"2000","journal-title":"Respir Res"},{"key":"10.1016\/j.scib.2023.07.032_b0300","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.2741\/3518","article-title":"Protein-protein interactions and gene expression regulation in HTLV-1 infected cells","volume":"14","author":"Legros","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.scib.2023.07.032_b0305","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.2343305","article-title":"Localization of PDGF-B protein in macrophages in all phases of atherogenesis","volume":"248","author":"Ross","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.scib.2023.07.032_b0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis","volume":"183","author":"Jain","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.scib.2023.07.032_b0315","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1582-4934.2010.01041.x","article-title":"Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment","volume":"15","author":"Simons","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.scib.2023.07.032_b0320","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2121-11-66","article-title":"Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway","volume":"11","author":"Fu","year":"2010","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0325","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvx025","article-title":"Macrophage migration inhibitory factor triggers vascular smooth muscle cell dedifferentiation by a p68-serum response factor axis","volume":"113","author":"Fan","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0330","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00395-012-0310-4","article-title":"Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis","volume":"108","author":"Kanzler","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.scib.2023.07.032_b0335","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2006.08.036","article-title":"P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin","volume":"127","author":"Yang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.scib.2023.07.032_b0340","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbagrm.2013.03.004","article-title":"The DEAD box proteins DDX5 (p68) and DDX17 (p72): multi-tasking transcriptional regulators","volume":"1829","author":"Fuller-Pace","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.scib.2023.07.032_b0345","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201709-1835OC","article-title":"Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension","volume":"198","author":"Dai","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2023.07.032_b0350","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1093\/nar\/gkm528","article-title":"Functional interactions between the Forkhead transcription factor FOXK1 and the MADS-box protein SRF","volume":"35","author":"Freddie","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.scib.2023.07.032_b0355","first-page":"92","article-title":"FoxM1: at the crossroads of ageing and cancer","volume":"1775","author":"Laoukili","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.scib.2023.07.032_b0360","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1165\/rcmb.2011-0128OC","article-title":"Hypoxia-induced pulmonary arterial smooth muscle cell proliferation is controlled by forkhead box M1","volume":"46","author":"Raghavan","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12964-019-0347-1","article-title":"The multifaceted roles of FOXM1 in pulmonary disease","volume":"17","author":"Li","year":"2019","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.scib.2023.07.032_b0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cellsig.2018.08.003","article-title":"Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension","volume":"51","author":"Dai","year":"2018","journal-title":"Cell Signal"},{"key":"10.1016\/j.scib.2023.07.032_b0375","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00314.2009","article-title":"Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension","volume":"298","author":"Firth","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nm.4109","article-title":"Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective","volume":"22","author":"Cherepanova","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.scib.2023.07.032_b0385","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1038\/s41598-018-27321-4","article-title":"The level of ROCK1 and ROCK2 in patients with pulmonary hypertension in plateau area","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.scib.2023.07.032_b0390","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/ATVBAHA.118.311714","article-title":"Aqp-1 gene knockout attenuates hypoxic pulmonary hypertension of mice","volume":"39","author":"Liu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0395","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","article-title":"Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2alpha inhibitor","volume":"198","author":"Dai","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2023.07.032_b0400","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/CIRCULATIONAHA.117.033113","article-title":"Selenoprotein P promotes the development of pulmonary arterial hypertension: possible novel therapeutic target","volume":"138","author":"Kikuchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0405","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/CIRCRESAHA.119.315758","article-title":"KCNK3 channel: a new player in the field of pulmonary vascular disease","volume":"125","author":"Babicheva","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0410","doi-asserted-by":"crossref","first-page":"158","DOI":"10.17305\/bjbms.2012.2463","article-title":"Hypoxia induces voltage-gated K+ (Kv) channel expression in pulmonary arterial smooth muscle cells through hypoxia-inducible factor-1 (HIF-1)","volume":"12","author":"Dong","year":"2012","journal-title":"Bosn J Basic Med Sci"},{"key":"10.1016\/j.scib.2023.07.032_b0415","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2014.6234","article-title":"Hypoxia-dependent reactive oxygen species signaling in the pulmonary circulation: focus on ion channels","volume":"22","author":"Veit","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.scib.2023.07.032_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102246","article-title":"HIF2A gain-of-function mutation modulates the stiffness of smooth muscle cells and compromises vascular mechanics","volume":"24","author":"Chan","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.scib.2023.07.032_b0425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine","volume":"151","author":"Dunham-Snary","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.scib.2023.07.032_b0430","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1152\/jappl.1997.82.4.1084","article-title":"Hypoxic vasoconstriction in pulmonary arterioles and venules","volume":"82","author":"Hillier","year":"1997","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0435","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/cvr\/cvy004","article-title":"Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension","volume":"114","author":"Stenmark","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0440","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1161\/CIRCULATIONAHA.105.609008","article-title":"An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension","volume":"113","author":"Bonnet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0445","doi-asserted-by":"crossref","unstructured":"Shimoda LA, Manalo DJ, Sham JS, et al. Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol, 2001, 281: L202-208.","DOI":"10.1152\/ajplung.2001.281.1.L202"},{"key":"10.1016\/j.scib.2023.07.032_b0450","doi-asserted-by":"crossref","unstructured":"Whitman EM, Pisarcik S, Luke T, et al. Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol, 2008, 294: L309-318.","DOI":"10.1152\/ajplung.00091.2007"},{"key":"10.1016\/j.scib.2023.07.032_b0455","doi-asserted-by":"crossref","unstructured":"Remillard CV, Yuan JX. Activation of K+ channels: an essential pathway in programmed cell death. Am J Physiol Lung Cell Mol Physiol, 2004, 286: L49-67.","DOI":"10.1152\/ajplung.00041.2003"},{"key":"10.1016\/j.scib.2023.07.032_b0460","doi-asserted-by":"crossref","unstructured":"Krick S, Platoshyn O, Sweeney M, et al. Nitric oxide induces apoptosis by activating K+ channels in pulmonary vascular smooth muscle cells. Am J Physiol Heart Circ Physiol, 2002, 282: H184-193.","DOI":"10.1152\/ajpheart.2002.282.1.H184"},{"key":"10.1016\/j.scib.2023.07.032_b0465","doi-asserted-by":"crossref","unstructured":"Yu AY, Frid MG, Shimoda LA, et al. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol, 1998, 275: L818-826.","DOI":"10.1152\/ajplung.1998.275.4.L818"},{"key":"10.1016\/j.scib.2023.07.032_b0470","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/CIRCRESAHA.111.263848","article-title":"Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension","volume":"110","author":"Marsboom","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0475","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1096\/fj.10-175018","article-title":"mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia","volume":"25","author":"Krymskaya","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0480","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","article-title":"Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology","volume":"9","author":"Semenza","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.scib.2023.07.032_b0485","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4899-7678-9_3","article-title":"Acquired mitochondrial abnormalities, including epigenetic inhibition of superoxide dismutase 2, in pulmonary hypertension and cancer: therapeutic implications","volume":"903","author":"Archer","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0490","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.114.006979","article-title":"Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension","volume":"131","author":"Ryan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0495","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.73.6.1100","article-title":"A redox-based O2 sensor in rat pulmonary vasculature","volume":"73","author":"Archer","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0500","doi-asserted-by":"crossref","unstructured":"Archer SL, Michelakis ED, Thebaud B, et al. A central role for oxygen-sensitive K+ channels and mitochondria in the specialized oxygen-sensing system. Novartis Found Symp, 2006, 272: 157-171.","DOI":"10.1002\/9780470035009.ch13"},{"key":"10.1016\/j.scib.2023.07.032_b0505","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1152\/jappl.1989.67.5.1903","article-title":"Simultaneous measurement of O2 radicals and pulmonary vascular reactivity in rat lung","volume":"67","author":"Archer","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0510","first-page":"219","article-title":"Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation","volume":"475","author":"Archer","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0515","first-page":"127","article-title":"Redox status in the control of pulmonary vascular tone","volume":"11","author":"Archer","year":"1986","journal-title":"Herz"},{"key":"10.1016\/j.scib.2023.07.032_b0520","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1152\/jappl.1989.66.1.167","article-title":"H2O2 and cGMP may function as an O2 sensor in the pulmonary artery","volume":"66","author":"Burke-Wolin","year":"1989","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0525","doi-asserted-by":"crossref","unstructured":"Mohazzab KM, Wolin MS. Properties of a superoxide anion-generating microsomal NADH oxidoreductase, a potential pulmonary artery pO2 sensor. Am J Physiol, 1994, 267: L823-831.","DOI":"10.1152\/ajplung.1994.267.6.L823"},{"key":"10.1016\/j.scib.2023.07.032_b0530","doi-asserted-by":"crossref","unstructured":"Omar HA, Mohazzab KM, Mortelliti MP, et al. O2-dependent modulation of calf pulmonary artery tone by lactate: potential role of H2O2 and cGMP. Am J Physiol, 1993, 264: L141-145.","DOI":"10.1152\/ajplung.1993.264.2.L141"},{"key":"10.1016\/j.scib.2023.07.032_b0535","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1152\/jappl.2001.90.6.2249","article-title":"Alterations in a redox oxygen sensing mechanism in chronic hypoxia","volume":"90","author":"Reeve","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0540","doi-asserted-by":"crossref","unstructured":"Gupte SA, Kaminski PM, Floyd B, et al. Cytosolic NADPH may regulate differences in basal Nox oxidase-derived superoxide generation in bovine coronary and pulmonary arteries. Am J Physiol Heart Circ Physiol, 2005, 288: H13-21.","DOI":"10.1152\/ajpheart.00629.2004"},{"key":"10.1016\/j.scib.2023.07.032_b0545","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/01.RES.0000024689.07590.C2","article-title":"Diversity in mitochondrial function explains differences in vascular oxygen sensing","volume":"90","author":"Michelakis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0550","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/35107085","article-title":"Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression","volume":"414","author":"Makino","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.07.032_b0555","doi-asserted-by":"crossref","first-page":"11032","DOI":"10.1074\/jbc.M208681200","article-title":"Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex","volume":"278","author":"Maynard","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.07.032_b0560","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10863-007-9081-2","article-title":"HIF-1 mediates the warburg effect in clear cell renal carcinoma","volume":"39","author":"Semenza","year":"2007","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.scib.2023.07.032_b0565","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","article-title":"Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target","volume":"121","author":"Archer","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0570","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1113\/JP277275","article-title":"Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension","volume":"597","author":"Cunningham","year":"2019","journal-title":"J Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0575","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.RES.0000219677.12988.e9","article-title":"Impact of TASK-1 in human pulmonary artery smooth muscle cells","volume":"98","author":"Olschewski","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0580","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCRESAHA.119.314793","article-title":"Characterization of Kcnk3-mutated rat, a novel model of pulmonary hypertension","volume":"125","author":"Lambert","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0585","doi-asserted-by":"crossref","unstructured":"Smirnov SV, Robertson TP, Ward JP, et al. Chronic hypoxia is associated with reduced delayed rectifier K+ current in rat pulmonary artery muscle cells. Am J Physiol, 1994, 266: H365-370.","DOI":"10.1152\/ajpheart.1994.266.1.H365"},{"key":"10.1016\/j.scib.2023.07.032_b0590","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1172\/JCI119774","article-title":"Hypoxia inhibits gene expression of voltage-gated K+ channel alpha subunits in pulmonary artery smooth muscle cells","volume":"100","author":"Wang","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0595","doi-asserted-by":"crossref","unstructured":"Suzuki H, Twarog BM. Membrane properties of smooth muscle cells in pulmonary hypertensive rats. Am J Physiol, 1982, 242: H907-915.","DOI":"10.1152\/ajpheart.1982.242.5.H907"},{"key":"10.1016\/j.scib.2023.07.032_b0600","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1152\/japplphysiol.00843.2012","article-title":"55th bowditch lecture: effects of chronic hypoxia on the pulmonary circulation: role of HIF-1","volume":"113","author":"Shimoda","year":"2012","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0605","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.RES.0000138952.16382.ad","article-title":"Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension","volume":"95","author":"Lin","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0610","doi-asserted-by":"crossref","unstructured":"Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and trpc channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol, 2004, 286: L848-858.","DOI":"10.1152\/ajplung.00319.2003"},{"key":"10.1016\/j.scib.2023.07.032_b0615","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.RES.0000227551.68124.98","article-title":"Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells","volume":"98","author":"Wang","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0620","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.taap.2019.02.017","article-title":"Inhibition of RhoA\/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1alpha-dependent functional TRPC channels","volume":"369","author":"Wang","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b0625","doi-asserted-by":"crossref","unstructured":"Wang Z, Yang K, Zheng Q, et al. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2019, 316: L216-L228.","DOI":"10.1152\/ajplung.00538.2017"},{"key":"10.1016\/j.scib.2023.07.032_b0630","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000341235","article-title":"Intracellular pH in the resistance vasculature: regulation and functional implications","volume":"49","author":"Boedtkjer","year":"2012","journal-title":"J Vasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0635","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2013.04.008","article-title":"H+-activated Na+ influx in the ventricular myocyte couples Ca2+-signalling to intracellular pH","volume":"61","author":"Garciarena","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.scib.2023.07.032_b0640","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/ajrcmb.14.2.8630263","article-title":"The role of Na+\/H+ exchange and growth factors in pulmonary artery smooth muscle cell proliferation","volume":"14","author":"Quinn","year":"1996","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0645","doi-asserted-by":"crossref","first-page":"L941","DOI":"10.1152\/ajplung.00528.2005","article-title":"HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes","volume":"291","author":"Shimoda","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0650","first-page":"62","article-title":"The role of endothelin-1 in pulmonary arterial hypertension","volume":"2014","author":"Chester","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.scib.2023.07.032_b0655","doi-asserted-by":"crossref","first-page":"L422","DOI":"10.1152\/ajplung.00475.2017","article-title":"Pulmonary artery smooth muscle cell HIF-1alpha regulates endothelin expression via microRNA-543","volume":"315","author":"Wang","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0660","doi-asserted-by":"crossref","unstructured":"Archer SL, Gomberg-Maitland M, Maitland ML, et al. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol, 2008, 294: H570-578.","DOI":"10.1152\/ajpheart.01324.2007"},{"key":"10.1016\/j.scib.2023.07.032_b0665","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1096\/fj.201600557R","article-title":"Loss of smooth muscle cell hypoxia inducible factor-1alpha underlies increased vascular contractility in pulmonary hypertension","volume":"31","author":"Barnes","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0670","first-page":"L256","article-title":"Endothelial HIF-2alpha contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition","volume":"314","author":"Tang","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0675","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1alpha","volume":"189","author":"Ball","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2023.07.032_b0680","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCRESAHA.112.300646","article-title":"Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation","volume":"112","author":"Kim","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0685","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s004240100679","article-title":"Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression","volume":"443","author":"Camenisch","year":"2001","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.scib.2023.07.032_b0690","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1006\/bbrc.1998.8543","article-title":"Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand","volume":"245","author":"Hu","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.scib.2023.07.032_b0695","doi-asserted-by":"crossref","first-page":"12645","DOI":"10.1074\/jbc.M011344200","article-title":"Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300\/CBP","volume":"276","author":"Yamashita","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.07.032_b0700","doi-asserted-by":"crossref","first-page":"L549","DOI":"10.1152\/ajplung.00081.2012","article-title":"Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1","volume":"304","author":"Pisarcik","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0705","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.febslet.2012.08.036","article-title":"Endothelin-1 induces hypoxia inducible factor 1alpha expression in pulmonary artery smooth muscle cells","volume":"586","author":"Li","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.scib.2023.07.032_b0710","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","article-title":"Direct regulation of TWIST by HIF-1alpha promotes metastasis","volume":"10","author":"Yang","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0715","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1152\/japplphysiol.00643.2013","article-title":"HIF and pulmonary vascular responses to hypoxia","volume":"116","author":"Shimoda","year":"2014","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0720","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.116.021494","article-title":"Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2alpha","volume":"133","author":"Dai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0725","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1073\/pnas.1602978113","article-title":"HIF2alpha-arginase axis is essential for the development of pulmonary hypertension","volume":"113","author":"Cowburn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b0730","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood-2008-04-153718","article-title":"Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 alpha mutation","volume":"112","author":"Gale","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.scib.2023.07.032_b0735","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI36362","article-title":"The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice","volume":"120","author":"Hickey","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0740","doi-asserted-by":"crossref","first-page":"1900378","DOI":"10.1183\/13993003.00378-2019","article-title":"Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension","volume":"54","author":"Hu","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.scib.2023.07.032_b0745","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI85715","article-title":"Clinical iron deficiency disturbs normal human responses to hypoxia","volume":"126","author":"Frise","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0750","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI30117","article-title":"Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo","volume":"117","author":"Rankin","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0755","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nsmb1222","article-title":"Iron-regulatory proteins limit hypoxia-inducible factor-2alpha expression in iron deficiency","volume":"14","author":"Sanchez","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0760","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1096\/fj.10-177378","article-title":"Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2alpha gain-of-function mutation","volume":"25","author":"Formenti","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.scib.2023.07.032_b0765","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cvr\/cvr356","article-title":"Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1","volume":"93","author":"Bauer","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0770","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1749-8090-5-32","article-title":"Thrombospondin-1 null mice are resistant to hypoxia-induced pulmonary hypertension","volume":"5","author":"Ochoa","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0775","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvv243","article-title":"HIF-2alpha-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction","volume":"109","author":"Labrousse-Arias","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0780","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/cvr\/cvq218","article-title":"Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation","volume":"88","author":"Bauer","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0785","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.matbio.2009.01.002","article-title":"Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress","volume":"28","author":"Isenberg","year":"2009","journal-title":"Matrix Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0790","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ebiom.2019.09.041","article-title":"Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1alpha-ADAM17 pathway","volume":"49","author":"Lian","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.scib.2023.07.032_b0795","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41569-018-0114-9","article-title":"Abdominal aortic aneurysm: update on pathogenesis and medical treatments","volume":"16","author":"Golledge","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.scib.2023.07.032_b0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","article-title":"Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease","volume":"74","author":"Alexander","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0805","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.scib.2023.07.032_b0810","doi-asserted-by":"crossref","first-page":"e006798","DOI":"10.1161\/JAHA.117.006798","article-title":"Molecular fingerprint for terminal abdominal aortic aneurysm disease","volume":"6","author":"Gabel","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.scib.2023.07.032_b0815","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.3390\/ijms21176334","article-title":"Genetic and epigenetic mechanisms underlying vascular smooth muscle cell phenotypic modulation in abdominal aortic aneurysm","volume":"21","author":"Gurung","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.scib.2023.07.032_b0820","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/ATVBAHA.116.308356","article-title":"Aortic aneurysm: in defense of the vascular smooth muscle cell","volume":"36","author":"Kim","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0825","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvu061","article-title":"Smooth muscle cell-specific HIF-1alpha deficiency suppresses angiotensin II-induced vascular remodelling in mice","volume":"102","author":"Imanishi","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0830","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/ATVBAHA.116.307784","article-title":"Hypoxia-inducible factor-1alpha in smooth muscle cells protects against aortic aneurysms-brief report","volume":"36","author":"Imanishi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0835","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.117.032184","article-title":"H19 induces abdominal aortic aneurysm development and progression","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0840","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ejcts\/ezu215","article-title":"BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro","volume":"47","author":"Wang","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0845","doi-asserted-by":"crossref","first-page":"46733","DOI":"10.1074\/jbc.M409002200","article-title":"Roles of Brahma and Brahma\/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2023.07.032_b0850","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.jtcvs.2014.06.072","article-title":"Renal and visceral protection in thoracoabdominal aortic surgery","volume":"148","author":"Aftab","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0855","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cvr\/cvu196","article-title":"Angiogenesis and remodelling in human thoracic aortic aneurysms","volume":"104","author":"Kessler","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0860","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/1359-6101(96)00001-9","article-title":"Tumor suppressor activity of the TGF-beta pathway in human cancers","volume":"7","author":"Markowitz","year":"1996","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.scib.2023.07.032_b0865","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.85.1.99","article-title":"Cultured porcine coronary artery smooth muscle cells. A new model with advanced differentiation","volume":"85","author":"Christen","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.scib.2023.07.032_b0870","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.8503012","article-title":"Proliferation of human smooth muscle cells promoted by lipoprotein(a)","volume":"260","author":"Grainger","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.scib.2023.07.032_b0875","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/ATVBAHA.117.309999","article-title":"TGFbeta (transforming growth factor-beta) blockade induces a human-like disease in a nondissecting mouse model of abdominal aortic aneurysm","volume":"37","author":"Lareyre","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0880","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jvs.2016.07.105","article-title":"A novel chronic advanced stage abdominal aortic aneurysm murine model","volume":"66","author":"Lu","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0885","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.282","article-title":"TGF-beta\/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A","volume":"5","author":"Shi","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.scib.2023.07.032_b0890","doi-asserted-by":"crossref","first-page":"H540","DOI":"10.1152\/ajpheart.91478.2007","article-title":"TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation","volume":"297","author":"Tsai","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b0895","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jvs.2008.11.096","article-title":"Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: potential role of Smad3 in regulation of SMC proliferation","volume":"49","author":"Edlin","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.scib.2023.07.032_b0900","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1172\/JCI115393","article-title":"Production of transforming growth factor beta 1 during repair of arterial injury","volume":"88","author":"Majesky","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.scib.2023.07.032_b0905","doi-asserted-by":"crossref","first-page":"10759","DOI":"10.1073\/pnas.90.22.10759","article-title":"Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia","volume":"90","author":"Nabel","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b0910","first-page":"19","article-title":"Hypoxia supports epicardial cell differentiation in vascular smooth muscle cells through the activation of the TGFbeta pathway","volume":"5","author":"Tao","year":"2018","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.scib.2023.07.032_b0915","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2017.11.002","article-title":"Coronary calcification as a mechanism of plaque\/media shrinkage in vessels treated with bioresorbable vascular scaffold: a multimodality intracoronary imaging study","volume":"269","author":"Zeng","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.scib.2023.07.032_b0920","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.5551\/jat.39271","article-title":"Impact of renal functional\/morphological dynamics on the calcification of coronary and abdominal arteries in patients with chronic kidney disease","volume":"24","author":"Ichii","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.scib.2023.07.032_b0925","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/ATVBAHA.116.306256","article-title":"Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus","volume":"37","author":"Yahagi","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0930","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.scib.2023.07.032_b0935","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b0940","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2012.06.004","article-title":"Passing the baton: the HIF switch","volume":"37","author":"Koh","year":"2012","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.scib.2023.07.032_b0945","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/ATVBAHA.119.312509","article-title":"Hypoxia triggers osteochondrogenic differentiation of vascular smooth muscle cells in an HIF-1 (hypoxia-inducible factor 1)-dependent and reactive oxygen species-dependent manner","volume":"39","author":"Balogh","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b0950","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2017.03.005","article-title":"Coronary artery calcification: from mechanism to molecular imaging","volume":"10","author":"Nakahara","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.scib.2023.07.032_b0955","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2013.09.035","article-title":"Coronary and carotid atherosclerosis: how useful is the imaging?","volume":"231","author":"Ibrahimi","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.scib.2023.07.032_b0960","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/01913123.2014.991884","article-title":"HIF-1alpha and VEGF: immunohistochemical profile and possible function in human aortic valve stenosis","volume":"39","author":"Perrotta","year":"2015","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.scib.2023.07.032_b0965","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/thoraxjnl-2012-203151","article-title":"Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality","volume":"69","author":"Williams","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.scib.2023.07.032_b0970","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.resinv.2015.01.002","article-title":"Low arterial blood oxygenation is associated with calcification of the coronary arteries in patients with chronic obstructive pulmonary disease","volume":"53","author":"Inoue","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.scib.2023.07.032_b0975","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2840-13-52","article-title":"The relationship between serum hypoxia-inducible factor 1alpha and coronary artery calcification in asymptomatic type 2 diabetic patients","volume":"13","author":"Li","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.scib.2023.07.032_b0980","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cvr\/cvs126","article-title":"Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study","volume":"94","author":"Naik","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b0985","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.kint.2016.05.020","article-title":"Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification","volume":"90","author":"Mokas","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.scib.2023.07.032_b0990","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201512-2380OC","article-title":"Role for runt-related transcription factor 2 in proliferative and calcified vascular lesions in pulmonary arterial hypertension","volume":"194","author":"Ruffenach","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.scib.2023.07.032_b0995","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/CIRCULATIONAHA.110.972745","article-title":"Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension","volume":"122","author":"Abdul-Salam","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.scib.2023.07.032_b1000","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.107.156745","article-title":"Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification","volume":"28","author":"Liberman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.redox.2016.08.015","article-title":"Redox signaling in cardiovascular pathophysiology: a focus on hydrogen peroxide and vascular smooth muscle cells","volume":"9","author":"Byon","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1010","doi-asserted-by":"crossref","first-page":"13730","DOI":"10.1038\/s41598-018-31877-6","article-title":"Advanced glycation end products accelerate calcification in VSMCs through HIF-1alpha\/PDK4 activation and suppress glucose metabolism","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.scib.2023.07.032_b1015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","article-title":"Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms","volume":"3","author":"Stirban","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.scib.2023.07.032_b1020","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1159\/000226225","article-title":"Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE\/p38 MAPK","volume":"46","author":"Tanikawa","year":"2009","journal-title":"J Vasc Res"},{"key":"10.1016\/j.scib.2023.07.032_b1025","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1038\/srep16577","article-title":"Pyruvate dehydrogenase kinase 4 promotes vascular calcification via SMAD1\/5\/8 phosphorylation","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.scib.2023.07.032_b1030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2261-13-13","article-title":"Advanced glycation end products accelerate rat vascular calcification through RAGE\/oxidative stress","volume":"13","author":"Wei","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.scib.2023.07.032_b1035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.kint.2016.10.011","article-title":"Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury","volume":"91","author":"Oh","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.scib.2023.07.032_b1040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2012.36","article-title":"Hypoxia-driven pathways in bone development, regeneration and disease","volume":"8","author":"Maes","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.scib.2023.07.032_b1045","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3389\/fphys.2019.01584","article-title":"Zinc inhibits HIF-prolyl hydroxylase inhibitor-aggravated VSMC calcification induced by high phosphate","volume":"10","author":"Nagy","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b1050","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1681\/ASN.2017050492","article-title":"Zinc inhibits phosphate-induced vascular calcification through TNFAIP3-mediated suppression of NF-kappaB","volume":"29","author":"Voelkl","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.scib.2023.07.032_b1055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.bi.55.070186.004405","article-title":"Metallothionein","volume":"55","author":"Hamer","year":"1986","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.scib.2023.07.032_b1060","first-page":"407","article-title":"Antioxidant role of metallothioneins: a comparative overview","volume":"46","author":"Viarengo","year":"2000","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMp0912328","article-title":"Erythropoiesis-stimulating agent\u2014time for a reevaluation","volume":"362","author":"Unger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2023.07.032_b1070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2215\/CJN.05040908","article-title":"Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA)","volume":"4","author":"Krapf","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.scib.2023.07.032_b1075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(88)90293-0","article-title":"Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy","volume":"1","author":"Raine","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2023.07.032_b1080","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-10-2577","article-title":"The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression","volume":"17","author":"Hedley","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b1085","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1158\/1078-0432.CCR-10-3298","article-title":"Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models","volume":"17","author":"Hedley","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b1090","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12325-017-0508-9","article-title":"A new approach to the management of anemia in CKD patients: a review on roxadustat","volume":"34","author":"Becker","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.scib.2023.07.032_b1095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/HP.S130526","article-title":"Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer","volume":"5","author":"Seeley","year":"2017","journal-title":"Hypoxia"},{"key":"10.1016\/j.scib.2023.07.032_b1100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000454818","article-title":"Effects of daprodustat, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor on anemia management in Japanese hemodialysis subjects","volume":"45","author":"Akizawa","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.scib.2023.07.032_b1105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/cpdd.342","article-title":"A randomized, placebo- and positive-controlled, single-dose, crossover thorough QT\/QTc study assessing the effect of daprodustat on cardiac repolarization in healthy subjects","volume":"6","author":"Caltabiano","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.scib.2023.07.032_b1110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.kint.2016.07.019","article-title":"Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease","volume":"90","author":"Pergola","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.scib.2023.07.032_b1115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000464476","article-title":"Clinical trial of vadadustat in patients with anemia secondary to stage 3 or 4 chronic kidney disease","volume":"45","author":"Martin","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.scib.2023.07.032_b1120","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/bcp.13584","article-title":"First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia","volume":"84","author":"Bottcher","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b1125","first-page":"107","article-title":"Pharmacological characterization of ZYAN1, a novel prolyl hydroxylase inhibitor for the treatment of anemia","volume":"66","author":"Jain","year":"2016","journal-title":"Drug Res"},{"key":"10.1016\/j.scib.2023.07.032_b1130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00498254.2016.1278287","article-title":"Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia","volume":"48","author":"Patel","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.scib.2023.07.032_b1135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40262-017-0551-3","article-title":"Phase I clinical study of ZYAN1, a novel prolyl-hydroxylase (PHD) inhibitor to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers","volume":"57","author":"Kansagra","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.scib.2023.07.032_b1140","article-title":"Roxadustat: not just for anemia","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b1145","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40262-021-01095-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of roxadustat","volume":"61","author":"Czock","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.scib.2023.07.032_b1150","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s40265-020-01384-y","article-title":"Daprodustat: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.scib.2023.07.032_b1155","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40265-020-01383-z","article-title":"Vadadustat: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.scib.2023.07.032_b1160","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/cmdc.202100133","article-title":"Structural basis of prolyl hydroxylase domain inhibition by molidustat","volume":"16","author":"Figg","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.scib.2023.07.032_b1165","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40265-022-01744-w","article-title":"First approval","volume":"82","author":"Desidustat","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.scib.2023.07.032_b1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173990","article-title":"JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: comparative study against recombinant erythropoietin in rat","volume":"898","author":"Shinozaki","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b1175","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/acsmedchemlett.7b00404","article-title":"Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia","volume":"8","author":"Ogoshi","year":"2017","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.scib.2023.07.032_b1180","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40265-020-01444-3","article-title":"Enarodustat: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.scib.2023.07.032_b1185","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1182\/blood-2022-164803","article-title":"Inhibition of hypoxia inducible factor prolyl hydroxylase by FG-4592 (roxadustat) increases erythropoietic stimulation in a mouse model of sickle cell disease","volume":"140","author":"Sharma","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.scib.2023.07.032_b1190","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2003-07-2535","article-title":"Congenital disorder of oxygen sensing: association of the homozygous chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors","volume":"103","author":"Gordeuk","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.scib.2023.07.032_b1195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa1810742","article-title":"Intravenous iron in patients undergoing maintenance hemodialysis","volume":"380","author":"Macdougall","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2023.07.032_b1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172532","article-title":"JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-\u03b1 protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor","volume":"859","author":"Fukui","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b1205","doi-asserted-by":"crossref","first-page":"F388","DOI":"10.1152\/ajprenal.00419.2019","article-title":"Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease","volume":"318","author":"Uchida","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b1210","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1215","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1021\/acs.jmedchem.8b01596","article-title":"Small-molecule modulators of the hypoxia-inducible factor pathway: development and therapeutic applications","volume":"62","author":"Li","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1220","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood.V82.12.3610.3610","article-title":"Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction","volume":"82","author":"Wang","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.scib.2023.07.032_b1225","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1124\/mol.107.034041","article-title":"Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase","volume":"71","author":"Jeon","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.scib.2023.07.032_b1230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1113\/jphysiol.2004.069757","article-title":"Inhibition of endogenous HIF inactivation induces angiogenesis in ischaemic skeletal muscles of mice","volume":"560","author":"Milkiewicz","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.scib.2023.07.032_b1235","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"McDonough","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b1240","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1021\/cb400088q","article-title":"Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases","volume":"8","author":"Chowdhury","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132004","article-title":"Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain","volume":"10","author":"Chan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.scib.2023.07.032_b1250","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1255","doi-asserted-by":"crossref","first-page":"11039","DOI":"10.1021\/acs.jmedchem.6b01242","article-title":"Discovery of N-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1\u20133 (HIF PHD1-3) for the treatment of anemia","volume":"59","author":"Debenham","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1260","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1021\/acs.jmedchem.7b00352","article-title":"1,2,4-triazolo-[1,5-a]pyridine HIF prolylhydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction","volume":"60","author":"Ahmed","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1265","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm201542d","article-title":"1,3,8-triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1\u20133 (HIF PHD1-3) for the treatment of anemia","volume":"55","author":"Vachal","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1270","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.119.258731","article-title":"TP0463518, a novel prolyl hydroxylase inhibitor, specifically induces erythropoietin production in the liver","volume":"371","author":"Kato","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.scib.2023.07.032_b1275","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1021\/acs.jmedchem.8b00549","article-title":"Click chemistry-based discovery of [3-hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as orally active hypoxia-inducing factor prolyl hydroxylase inhibitors with favorable safety profiles for the treatment of anemia","volume":"61","author":"Wu","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1280","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jinorgbio.2012.03.002","article-title":"Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)","volume":"113","author":"Flagg","year":"2012","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.scib.2023.07.032_b1285","doi-asserted-by":"crossref","first-page":"15351","DOI":"10.1073\/pnas.202614999","article-title":"Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway","volume":"99","author":"Dann","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.scib.2023.07.032_b1290","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1021\/ja050841b","article-title":"Selective inhibition of factor inhibiting hypoxia-inducible factor","volume":"127","author":"McDonough","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2023.07.032_b1295","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1038\/ncomms13312","article-title":"Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition","volume":"7","author":"Frost","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.07.032_b1300","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1305","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41467-017-00954-1","article-title":"Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation","volume":"8","author":"Maniaci","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.scib.2023.07.032_b1310","doi-asserted-by":"crossref","unstructured":"Schneider M, Van Geyte K, Fraisl P, et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia\/reperfusion injury. Gastroenterology, 2010, 138: 1143-1154.","DOI":"10.1053\/j.gastro.2009.09.057"},{"key":"10.1016\/j.scib.2023.07.032_b1315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gene.2018.08.012","article-title":"The molecular characterization, expression pattern and alternative initiation of megalobrama amblycephala HIF prolyl hydroxylase PHD1","volume":"678","author":"Chen","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.scib.2023.07.032_b1320","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","article-title":"Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch","volume":"295","author":"Lando","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.scib.2023.07.032_b1325","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1021\/ja412434f","article-title":"Discovery and optimization of small-molecule ligands for the CBP\/p300 bromodomains","volume":"136","author":"Hay","year":"2014","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.scib.2023.07.032_b1330","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cbpa.2010.03.022","article-title":"A complex task? Direct modulation of transcription factors with small molecules","volume":"14","author":"Koehler","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1335","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41589-019-0234-5","article-title":"Bidirectional modulation of HIF-2 activity through chemical ligands","volume":"15","author":"Wu","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.scib.2023.07.032_b1340","doi-asserted-by":"crossref","first-page":"9691","DOI":"10.1021\/acs.jmedchem.8b01196","volume":"61","author":"In","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1345","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19795","article-title":"On-target efficacy of a HIF-2\u03b1 antagonist in preclinical kidney cancer models","volume":"539","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.07.032_b1350","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","article-title":"A small-molecule antagonist of HIF2\u03b1 is efficacious in preclinical models of renal cell carcinoma","volume":"76","author":"Wallace","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b1355","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1200\/JCO.2017.74.2627","article-title":"Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2\u03b1 antagonist in patients with previously treated advanced clear cell renal cell carcinoma","volume":"36","author":"Courtney","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.scib.2023.07.032_b1360","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1021\/acs.jmedchem.9b00719","article-title":"3-[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) inhibitor for the treatment of clear cell renal cell carcinoma","volume":"62","author":"Xu","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.scib.2023.07.032_b1365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/03602532.2017.1293682","article-title":"Glucuronidation: driving factors and their impact on glucuronide disposition","volume":"49","author":"Yang","year":"2017","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.scib.2023.07.032_b1370","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19796","article-title":"Targeting renal cell carcinoma with a HIF-2 antagonist","volume":"539","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.scib.2023.07.032_b1375","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1078-0432.CCR-19-1459","article-title":"HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma","volume":"26","author":"Courtney","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.scib.2023.07.032_b1380","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.scib.2021.04.008","article-title":"Hypertrophic preconditioning attenuates myocardial ischemia\/reperfusion injury through the deacetylation of isocitrate dehydrogenase 2","volume":"66","author":"Ma","year":"2021","journal-title":"Sci Bull"},{"key":"10.1016\/j.scib.2023.07.032_b1385","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0330-2020","article-title":"Sex and gender in pulmonary arterial hypertension","volume":"30","author":"Cheron","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.scib.2023.07.032_b1390","doi-asserted-by":"crossref","first-page":"e011628","DOI":"10.1161\/JAHA.118.011628","article-title":"Influence of 2-methoxyestradiol and sex on hypoxia-induced pulmonary hypertension and hypoxia-inducible factor-1-alpha","volume":"8","author":"Docherty","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.scib.2023.07.032_b1395","doi-asserted-by":"crossref","first-page":"11459","DOI":"10.1073\/pnas.1002443107","article-title":"Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in tibetan highlanders","volume":"107","author":"Beall","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323004814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927323004814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:55:51Z","timestamp":1761868551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927323004814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":279,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2095927323004814"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2023.07.032","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2023.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Science China Press. Published by Elsevier B.V. and Science China Press.","name":"copyright","label":"Copyright"}]}}